Tech Company Financing Transactions
Atreo Funding Round
On 8/9/2022, Atreo raised $4 million in Seed investment from private investors.
Transaction Overview
Company Name
Announced On
8/9/2022
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Seed
Investors
Proceeds Purpose
Atreo, Inc., a Clinical Development SaaS Clinical Development SaaS company focused on modernizing and simplifying the clinical trials process,
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
230 California St 302
San Francisco, CA 94111
USA
San Francisco, CA 94111
USA
Phone
Website
Email Address
Overview
Atreo has embraced and focused on a simple mantra: Time Better Spent. Time is the most valuable asset for our clients, Atreo team members, and most critically for patients enrolled in clinical trials. Our RTSM solutions will help bring lifesaving therapeutics to market faster, more collaboratively, and with significantly higher quality, ensuring Time Better Spent becomes the expectation of Atreo's partners and patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ryan Harrison
Chief Operating Officer
Jon Ball
Chief Technical Officer
John Ranz
Browse more venture capital transactions:
Prev: 8/9/2022: Overtime venture capital transaction
Next: 8/9/2022: Nanopath venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs